Taking human cancer genes to the fish: A transgenic model of melanoma in zebrafish

Zebrafish

Volumn 1, Issue 4, 2005, Pages 363-368

  Patton, E Elizabeth ^a,b   Zon, Leonard I ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DANIO RERIO;

EID: 15944428992     PISSN: 15458547     EISSN: None     Source Type: Journal    
DOI: 10.1089/zeb.2005.1.363     Document Type: Conference Paper

References (27)

1. Tucker MA, Goldstein AM. Melanoma etiology: where are we? Oncogene 2003;22:3042-3052.
2. Soengas MS, Lowe SW. Apoptosis and melanoma chemoresistance. Oncogene 2003;22:3138-3151.
3. Sharpless E, Chin L. The INK4a/ARF locus and melanoma. Oncogene 2003;22:3092-3098.
4. Walter RB, Kazianis S. Xiphophorus interspecies hybrids as genetic models of induced neoplasia. ILAR J 2001;42:299-321.
5. Wellbrock C, Gomez A, Schartl M. Melanoma development and pigment cell transformation in Xiphophorus. Microsc Res Tech 2002;58:456-463.
6. Chin L. The genetics of malignant melanoma: lessons from mouse and man. Nature Rev Cancer 2003;3:559-570.
7. Lowe SW, Sherr CJ. Tumor suppression by Ink4a-Arf: progress and puzzles. Curr Opin Genet Dev 2003;13:77-83.
8. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA. Mutations of the BRAF gene in human cancer. Nature 2002;417:949-954.
9. Tuveson DA, Weber B L, Herlyn M. BRAF as a potential therapeutic target in melanoma and other malignancies. Cancer Cell 2003;4:95-98.
10. Dibb NJ, Dilworth SM, Clifford DM. Switching on the kinases: oncogenic activation of BRAF and the PDGFR family. Nat Rev Can 2004;4:718-727.
11. Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, Moses TY, Hostetter G, Wagner U, Kakareka J, Salem G, Pohida T, Heenan P, Duray P, Kallioniemi O, Hayward NK, Trent JM, Meltzer PS. High frequency of BRAF mutations in nevi. Nat Genet 2003;33:19-20.
12. Smalley SM, Herlyn M. Loitering with intent: new evidence for the role of BRAF mutations in the proliferation of melanocytic lesions. Soc Invest Derm 2004;123:xvi-xvii.
13. Patton EE, Widlund HR, Kutok JL, Kopani KR, Amatruda JF, Murphey RD, Berghmans S, Mayhall EA, Traver D, Fletcher CD, Aster JC, Granter SR, Look AT, Lee C, Fisher DE, Zon LI. BRAF mutations are sufficient to promote nevi formation, and cooperate with p53 in the genesis of melanoma. Curr Biol 2005 in press.
14. Lister JA, Close J, Raible DW. Duplicate mitf genes in zebrafish: complementary expression and conservation of melanogenic potential. Dev Biol 2001;237:333-344.
15. Widlund HR, Fisher DE. Microphthalamia-associated transcription factor: a critical regulator of pigment cell development and survival. Oncogene 2003;22:3035-3041.
16. Tanami H, Imoto I, Hirasawa A, Yuki Y, Sonoda I, Inoue J, Yasui K, Misawa-Furihata A, Kawakami Y, Inazawa J. Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines. Oncogene 2004;23:8796-8804.
17. Gimenez-Conti I, Woodhead AD, Harshbarger JC, Kazianis S, Setlow RB, Nairn RS, Walter RB. A proposed classification scheme for Xiphophorus melanomas based on histopathologic analyses. Mar Biotechnol (NY) 2001;3:S100-106.
18. Berghmans S, Murphey RD, Wienholds E, Neuberg D, Kutok JL, Fletcher CDM, Morris JP, Liu TX, Schulte-Merker S, Kanki JP, Plasterk R, Zon LI, Look AT. Malignant peripheral nerve sheath tumors in tp53 mutant zebrafish. PNAS (USA) 2005 in press
19. Sharpless NE, Kannan K, Xu J, Bosenberg MW, Chin L. Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo. Oncogene 2003;22:5055-5059.
20. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P. The IARC TP53 Database: new online mutation analysis and recommendations to users. Hum Mutat 2002;19:607-614.
21. Traver D, Winzeler A, Stern HM, Mayhall EA, Langenau DM, Kutok JL, Look AT, Zon LI. Effects of lethal irradiation in zebrafish and rescue by hematopoietic cell transplantation. Blood 2004;104:1298-1305.
22. Bastian BC. Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer. Oncogene 2003;22:3081-3086.
23. Stern HM, Zon LI. Cancer genetics and drug discovery in the zebrafish. Nat Rev Cancer 2003;3:533-539.
24. Patton EE, Zon LI. The art and design of genetic screens: zebrafish. Nat Rev Genet 2001;12:956-966.
25. Jhappan C, Noonan FP, Merlino G. Ultraviolet radiation and cutaneous malignant melanoma. Oncogene 2003;22:3099-3112.
26. Maldonado JL, Fridlyand J, Patel H, Jain AN, Busam K, Kageshita T, Ono T, Albertson DG, Pinkel D, Bastian BC. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 2003;95:1878-1890.
27. Peterson RT, Shaw SY, Peterson TA, Milan DJ, Zhong TP, Schreiber SL, MacRae CA, Fishman MC. Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nat Biotechnol 2004;22:595-599.